Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (2)
Country
  • Australia (2)
  • Belgium (2)
  • Canada (2)
  • Finland (2)
  • France (2)
  • Germany (2)
  • Italy (2)
  • Korea, Republic of (2)
  • Poland (2)
  • Spain (2)
  • Sweden (2)
  • United Kingdom (2)
  • United States (2)
  • Argentina (1)
  • Austria (1)
  • Colombia (1)
  • Egypt (1)
  • Guatemala (1)
  • Hungary (1)
  • Iceland (1)
  • India (1)
  • Israel (1)
  • Netherlands (1)
  • Norway (1)
  • Philippines (1)
  • Romania (1)
  • Singapore (1)
  • Taiwan, Province of China (1)
Source
  • nct (2)
Phase
  • complete (1)
  • terminated (1)

Country: Australia,Korea, Republic of,United Kingdom,Belgium,Poland,Canada,Italy
nct Update Il y a 5 ans

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis This study will assess the safety and efficacy of secukinumab compared to placebo and etanercept in patients that have moderate to severe, chronic, plaque-type psoriasis.

  • Country Argentina, Australia, Belgium, Canada, Colombia, Egypt, Finland, France, Germany, Guatemala, Hungary, Iceland, India, Italy, Korea, Republic of, Philippines, Poland, Romania, Singapore, Spain, Sweden, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information
nct Update Il y a 5 ans

A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma The primary purpose of this study is to see how tasisulam affects metastatic melanoma when compared against paclitaxel as measured by overall survival.

  • Country Australia, Austria, Belgium, Canada, Finland, France, Germany, Israel, Italy, Korea, Republic of, Netherlands, Norway, Poland, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.